UPDATE : Tuesday, December 18, 2018
상단여백
Chong Kun Dang recruits European researchers for autoimmune disease drug
Chong Kun Dang said Monday that it has gathered European clinical researche...
by Lee Han-soo  |  2018-10-16 12:08
라인
‘AI-based drug development to broaden gap between pharmaceuticals’
Local pharmaceutical firms should brace for a new era where drugmakers take...
by So Jae-hyeon  |  2018-10-15 15:37
라인
[News Focus] Handok sidesteps regulation to promote anti-Alzheimer drink
The medical community and pharmaceutical industry have raised suspicion tha...
by So Jae-hyeon  |  2018-10-15 14:52
라인
Sanofi-Aventis Korea unveils sub-analysis for dyslipidemia therapy
Sanofi-Aventis Korea said Friday that it has published the results of ODYSS...
by Lee Han-soo  |  2018-10-12 17:25
라인
Abbvie’s hepatitis C drug expands indication
Abbvie’s Maviret, a hepatitis C treatment, has received approval for additi...
by Lee Han-soo  |  2018-10-12 15:40
라인
[News Focus] Celltrion to accelerate US entry on imminent FDA approval
Cellrion is expected to accelerate its move to enter the U.S. market with a...
by So Jae-hyeon  |  2018-10-12 15:40
라인
Bridge Bio completes phase-1 study for ulcerative colitis drug in US
Bridge Biotherapeutics said Friday that it has completed phase-1 clinical t...
by Lee Han-soo  |  2018-10-12 13:38
라인
Boryung to export anticancer drugs to Philippine
Boryung Pharmaceutical said Friday that it has signed a deal with Endure Me...
by Lee Han-soo  |  2018-10-12 13:26
라인
[News Focus] Authorities close in on drug firm owners in bribery case
The issue of illegal rebates is stirring the Korean pharmaceutical sector, ...
by So Jae-hyeon  |  2018-10-11 16:33
라인
YD Life Science wins source tech for anti-cancer gene therapy
YD Life Science said Wednesday that it has signed a technology transfer agr...
by Lee Han-soo  |  2018-10-11 14:46
라인
BMS to test cabiralizumab+nivolumab for pancreatic cancer
Bristol-Myers Squibb is soon to conduct phase-2 trials in Korea on its immu...
by Lee Hye-seon  |  2018-10-11 14:23
라인
Anticipation grows for Lenvima as new liver cancer drug
Eisai Korea’s Lenvima (lenvatinib), recently approved as a first-line treat...
by Nam Doo-hyun  |  2018-10-11 11:44
라인
Kukje Pharm CEO, executives booked for bribing doctors
A midsize Korean pharmaceutical company has been embroiled in an illegal re...
by So Jae-hyeon  |  2018-10-10 15:31
라인
Hanmi unveils test results for asthma-rhinitis combination drug in US
Hanmi said Wednesday that it has presented its phase 3 clinical trial resul...
by Lee Han-soo  |  2018-10-10 12:08
라인
‘Medytox performance depends on Chinese regulations on peddlers’
Medytox’s performance in the fourth quarter will rely on the Chinese govern...
by Nam Doo-hyun  |  2018-10-08 16:59
라인
Abbott’s hepatitis B antibody reagent recalled due to error
The government ordered Korea Abbott to recall its hepatitis B antibody reag...
by Lee Hye-seon  |  2018-10-08 15:52
라인
Amantadine sulfate to lose indication for influenza A virus treatment
The government said it would change approval conditions for two pharmaceuti...
by Lee Hye-seon  |  2018-10-08 15:49
라인
Pharmaceuticals seek fresh start with new CEOs
Several pharmaceutical and biotech firms have appointed a new CEO or a vice...
by So Jae-hyeon  |  2018-10-05 15:44
라인
Allergan’s eye implant recalled due to foreign substance
Allergan is recalling Ozurdex Intravitreal Implant 700㎍ (ingredient: dexame...
by Lee Hye-seon  |  2018-10-05 13:53
라인
Daewoong to refile clinical trial plan on botulinum toxin in China
Daewoong Pharmaceutical has changed its strategy of entering the Chinese ma...
by So Jae-hyeon  |  2018-10-05 12:00
여백
여백
여백
Back to Top